John J. Kirby - Insider Trading & Ownership

Location
C/O Idera Pharmaceuticals, Inc., 505 Eagleview Blvd., Suite 212, Exton, PA
Summary
The estimated net worth of John J. Kirby is at least $295K dollars as of November 6, 2024. John J. Kirby is the CHIEF FINANCIAL OFFICER of Aceragen, Inc. and owns shares of Aceragen, Inc. stock worth about $162K. John J. Kirby is the Interim CFO of Verrica Pharmaceuticals Inc. and owns shares of Verrica Pharmaceuticals Inc. (VRCA) stock worth about $133K.
Signature
/s/ Christopher Hayes, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of John J. Kirby

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACGN Aceragen, Inc. Chief Financial Officer $162K Jan 20, 2023
VRCA Verrica Pharmaceuticals Inc. Interim CFO $133K Nov 6, 2024

Insider Transactions Reported by John J. Kirby:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.